• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Barclays Bank PLC Apr 11 Product Image

Barclays Bank PLC Apr 11

  • ID: 1718181
  • April 2011
  • Standard & Poors

FEATURED COMPANIES

  • Barclays Bank Ireland PLC
  • Barclays Bank Mexico S.A.
  • Barclays Bank PLC
  • Barclays Bank S.A.U.
  • Barclays PLC
  • Barclays US Funding LLC
  • MORE

Abstract
Leading business positions in core markets. Reasonably diversified revenue base by business line and geography. Strengthened liquidity position. Relatively resilient earnings performance. Revenue volatility and confidence sensitivity of extensive investment banking activities. Material residual exposures to legacy credit market assets. Risks inherent in substantial loan portfolios. The ratings on U.K. bank Barclays Bank PLC reflect Standard & Poor's Ratings Services' opinion of its robust business profile and less strong, but improving, financial profile. We consider that Barclays has a strong and diverse franchise by business line and geography, but with a relatively overweight position in investment banking through its Barclays Capital (BarCap) division. BarCap's performance has been volatile in recent years, reflecting cyclicality in revenues and write-downs. BarCap's share of...

Companies mentioned in this report are:
- Barclays Bank PLC
- Barclays Bank S.A.U.
- Absa Bank Ltd. (Unsolicited Ratings)
- Barclays Bank PLC (Australian Branch)
- Barclays Private Clients International Ltd.
- Barclays US Funding LLC
- Barclays Bank Ireland PLC
- READ MORE >

Note: Product cover images may vary from those shown

- Barclays Bank PLC
- Barclays Bank S.A.U.
- Absa Bank Ltd. (Unsolicited Ratings)
- Barclays Bank PLC (Australian Branch)
- Barclays Private Clients International Ltd.
- Barclays US Funding LLC
- Barclays Bank Ireland PLC
- Barclays Bank Mexico S.A.
- Barclays PLC

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.